ImmunityBio, Inc. (IBRX)
7.875
-0.08
(-0.94%)
USD |
NASDAQ |
Sep 01, 16:00
7.86
-0.02
(-0.19%)
After-Hours: 17:23
ImmunityBio Total Long Term Debt (Quarterly) : 1.221B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.221B |
| March 31, 2026 | 1.116B |
| December 31, 2025 | 837.13M |
| September 30, 2025 | 853.92M |
| June 30, 2025 | 835.28M |
| March 31, 2025 | 815.10M |
| December 31, 2024 | 782.35M |
| September 30, 2024 | 1.012B |
| June 30, 2024 | 992.71M |
| March 31, 2024 | 889.34M |
| December 31, 2023 | 878.43M |
| September 30, 2023 | 715.32M |
| June 30, 2023 | 813.28M |
| March 31, 2023 | 763.89M |
| December 31, 2022 | 722.68M |
| September 30, 2022 | 713.08M |
| June 30, 2022 | 625.37M |
| March 31, 2022 | 611.79M |
| December 31, 2021 | 642.65M |
| September 30, 2021 | 342.02M |
| June 30, 2021 | 330.00M |
| March 31, 2021 | 314.41M |
| December 31, 2020 | 11.24M |
| September 30, 2020 | 13.51M |
| Date | Value |
|---|---|
| June 30, 2020 | 9.462M |
| March 31, 2020 | 10.56M |
| December 31, 2019 | 11.64M |
| September 30, 2019 | 12.86M |
| June 30, 2019 | 12.00M |
| March 31, 2019 | 12.84M |
| December 31, 2018 | 6.91M |
| September 30, 2018 | 7.303M |
| June 30, 2018 | 6.852M |
| March 31, 2018 | 7.023M |
| December 31, 2017 | 7.268M |
| September 30, 2017 | 7.507M |
| June 30, 2017 | 22.36M |
| March 31, 2017 | 7.981M |
| December 31, 2016 | 8.21M |
| September 30, 2016 | 7.703M |
| June 30, 2016 | 2.417M |
| March 31, 2016 | 2.451M |
| December 31, 2015 | 2.468M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Moderna, Inc. | 1.266B |
| Sarepta Therapeutics, Inc. | 1.046B |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Oncolytics Biotech, Inc. | 0.31M |
| Sangamo Therapeutics, Inc. | 19.33M |